Arginine reprograms metabolism in liver cancer via RBM39
2023 · Cell · 237 citations
https://doi.org/10.1016/j.cell.2023.09.011
V
Verónica Jiménez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
2.1K
Citations
23
h-index
29
i10-index
Verónica Jiménez is an academic researcher from Universitat Autònoma de Barcelona. The author has contributed to research in topics: Pancreatic function and diabetes & Virus-based gene therapy research & Diabetes and associated disorders. The author has an h-index of 23, co-authored 44 publications.
ORCID: 0000-0001-9145-9877Papers by this author
worksInsulin-like Growth Factor 2 Overexpression Induces β-Cell Dysfunction and Increases Beta-cell Susceptibility to Damage
2015 · Journal of Biological Chemistry · 68 citations
https://doi.org/10.1074/jbc.m115.642041
In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9
2011 · Diabetologia · 65 citations
https://doi.org/10.1007/s00125-011-2070-3
Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist
2022 · Nature Communications · 24 citations
https://doi.org/10.1038/s41467-022-34391-6
Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy
2024 · Molecular Metabolism · 16 citations
https://doi.org/10.1016/j.molmet.2024.101899
Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy
2024 · Molecular Therapy · 14 citations
https://doi.org/10.1016/j.ymthe.2024.10.023
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat